QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Related Article All Versions of this Article: mol.108.052944v1 75/1/13    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Related articles in MolPharm Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Seifert, R. Articles by Dove, S. Search for Related Content PubMed PubMed Citation Articles by Seifert, R. Articles by Dove, S.

Perspective

Functional Selectivity of GPCR Ligand Stereoisomers: New Pharmacological Opportunities

Department of Pharmacology, Medical School of Hannover, Hannover, Germany (R.S.); and Department of Pharmaceutical and Medicinal Chemistry II, University of Regensburg, Regensburg, Germany (S.D.)

It is now well established that any given ligand for a G-protein-couple receptor (GPCR) does not simply possess a single defined efficacy. Rather, a ligand possesses multiple efficacies, depending on the specific down-stream signal transduction pathway analyzed. This diversity may be based on ligand-specific GPCR conformations and is often referred to as "functional selectivity." It has been known for a century that stereoisomers of catecholamines differ in their potency and, in some systems, also in their efficacy. However, the molecular basis for efficacy differences of GPCR ligand stereoisomers has remained poorly defined. In an elegant study published in this issue of Molecular Pharmacology, Woo et al. (p. 158) show that stereoisomers of the β₂-adrenoceptor selective agonist fenoterol differentially activates G_s- and G_i-proteins in native rat cardiomyocytes. This study is so important because it is the first report to show that even the subtle structural differences within a ligand stereoisomer pair are sufficient to discriminate between GPCR conformations with distinct G-protein coupling properties. The study highlights of how important it is to examine the "more active" (eutomer) and the "less active" (distomer) stereoisomer to understand the mechanisms of action and the cellular effects of GPCR ligands. The study by Woo et al. will ignite a renaissance of the analysis of ligand stereoisomers, using sensitive pharmacological and biophysical assays. The available literature supports the notion that meticulous analysis of ligand stereoisomers is a goldmine for understanding mechanisms of GPCR activation, analysis of signal transduction pathways, development of new therapies for important diseases, and drug safety.

Received for publication October 21, 2008.

Accepted for publication October 21, 2008.

Address correspondence to: Dr. Roland Seifert, Department of Pharmacology, Medical School of Hannover, Carl-Neuberg-Straße 1, D-30625 Hannover, Germany. E-mail: seifert.roland{at}mh-hannover.de

Related articles in MolPharm:

Stereochemistry of an Agonist Determines Coupling Preference of β₂-Adrenoceptor to Different G Proteins in Cardiomyocytes

Anthony Yiu-Ho Woo, Tian-Bing Wang, Xiaokun Zeng, Weizhong Zhu, Darrell R. Abernethy, Irving W. Wainer, and Rui-Ping Xiao
MolPharm 2009 75: 158-165. [Abstract] [Full Text]